Sandip I. Patel

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Tampa, FL
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jason Simon, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Sandip I. Patel

Form 4 holding Director

Akari Therapeutics Plc

Security class
American Depositary Shares representing Ordinary Shares
Shares / value
38,877
Estimated value
$506,080
Report date
14 Oct 2026
Price
$1.12
Ownership
Direct
Form 4 holding Director

Akari Therapeutics Plc

Security class
Pre-Funded Warrants to purchase ADRs
Shares / value
154,664
Estimated value
$62,499
Report date
16 Dec 2025
Price
$0.4041
Ownership
Direct
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director

Akari Therapeutics Plc

Security class
Series A Warrants (Right to Buy)
Shares / value
44,642
Estimated value
$49,999
Report date
06 Mar 2025
Price
$1.12
Ownership
Direct
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director

Akari Therapeutics Plc

Security class
Series B Warrants (Right to Buy)
Shares / value
44,642
Estimated value
$49,999
Report date
06 Mar 2025
Price
$1.12
Ownership
Direct
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director

Akari Therapeutics Plc

Security class
American Depositary Shares representing Ordinary Shares
Shares / value
20,219
Estimated value
$22,645
Report date
25 Apr 2025
Price
$1.12
Ownership
Davis Island Ventures LLC
Form 4 holding Director

Akari Therapeutics Plc

Security class
American Depositary Shares representing Ordinary Shares
Shares / value
19,880
Estimated value
$22,266
Report date
25 Apr 2025
Price
$1.12
Ownership
Quest Bio LLC
Form 4 holding Director

Akari Therapeutics Plc

Security class
American Depositary Shares representing Ordinary Shares
Shares / value
13,901
Estimated value
$15,569
Report date
20 Mar 2025
Price
$1.12
Ownership
Innovative Lifesci Investment LLC
Form 4 holding Director

Akari Therapeutics Plc

Security class
American Depositary Shares representing Ordinary Shares
Shares / value
6,250
Estimated value
$7,000
Report date
25 Apr 2025
Price
$1.12
Ownership
TT Insurance Investment LLC
Form 4 holding Director

Peak Bio, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
14 Nov 2024
Price
$0.2650
Ownership
Direct
Form 4 holding Director

Peak Bio, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
14 Nov 2024
Price
$0.2650
Ownership
Indirect
Form 4 holding CFO and General Counsel, Director

AtlasClear Holdings, Inc.

Security class
Stock Option (right to buy)
Shares / value
777,332
Estimated value
Report date
01 Oct 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CFO and General Counsel, Director

AtlasClear Holdings, Inc.

Security class
Warrants
Shares / value
354,088
Estimated value
Report date
20 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Akari Therapeutics Plc

Security class
Warrants to purchase American Depositary Shares ("ADRs")
Shares / value
247,462
Estimated value
Report date
16 Dec 2025
Price
Ownership
Direct
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director

Akari Therapeutics Plc

Security class
Warrants to purchase ADRs
Shares / value
154,664
Estimated value
Report date
16 Dec 2025
Price
Ownership
Direct
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director

Akari Therapeutics Plc

Security class
Stock Option (Right to Buy)
Shares / value
15,000
Estimated value
Report date
18 Aug 2026
Price
Ownership
Direct
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director

Akari Therapeutics Plc

Security class
American Depositary Shares representing Ordinary Shares
Shares / value
13,901
Estimated value
Report date
25 Apr 2025
Price
Ownership
Innovative Lifesci Investments LLC
Form 4 holding Director

Akari Therapeutics Plc

Security class
Pre-Funded Warrant to Purchase ADSs
Shares / value
0
Estimated value
Report date
14 Oct 2026
Price
Ownership
Direct
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director

Peak Bio, Inc.

Security class
Convertible Notes
Shares / value
0
Estimated value
Report date
14 Nov 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Peak Bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
14 Nov 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Sandip I. Patel

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .